Is Iran’s diabetes cascade improving over time?
From 2004–2016 prevalence rose 8.4%→13.2% and awareness 53.5%→82.2%, but treatment (~36–46%) and control (~15–21%) stayed suboptimal.
Source
Prevalence, awareness, treatment and control of diabetes among Iranian population: results of four national cross-sectional STEPwise approach to surveillance surveys
What they did
Analyzed four STEPS NCD surveys with descriptive stats and logistic regression for sociodemographic correlates of awareness/treatment/control.
What they found
Prevalence and awareness climbed; treatment peaked then dipped; control remained low. Female sex, age>40, urban residence, mid wealth, and insurance associated with prevalence.
The limits
What it doesn't show
Does not evaluate a specific intervention trial; age/sex unadjusted prevalence trends as reported.
Key terms
- STEPS
- WHO STEPwise approach to NCD risk-factor surveillance.
- Awareness
- Share of people with diabetes who know their diagnosis.
- Treatment
- Share receiving therapy among those with diabetes.
- Glycemic control
- Adequate blood glucose control among diabetic patients.
- Effective coverage
- Cascade from disease → awareness → treatment → control.
- NCD
- Non-communicable disease.
Flashcards
Research intelligence for this paper
See its role on concept claims, tensions it is part of, placement history, and related discoveries.
Quiz yourself
2016 prevalence ≈
Common questions
Prevalence trend?
8.4% → 9% → 11.1% → 13.2%.
Awareness 2016?
82.2%.
Control in 2016?
18.5%.
Age band?
25–65 years.
More on public-health